Health & Biotech
Stockhead’s resident Health and Biotech expert Tim Boreham is putting down the pen and picking up the microphone for another instalment of The Health Kick Podcast.
In this episode Tim chats with Dr Sud Agarwal, Chief Medical Officer at Incannex Healthcare (ASX: IHL).
The company grabbed headlines in August with the announcement that its COVID-19 treatment performed well in the lab against sepsis associated acute respiratory distress syndrome, or SAARDS, a cause of death in patients with the illness.
Click below to hear more about the company’s transition into cannabinoid treatments, it’s novel treatment and orphan segment targeting, progress this year and plans for the year ahead.
On mobile? Click here to listen with Apple podcasts, here for Spotify or here for Google Podcasts.
Like to listen to podcasts through another app? Just search for The Health Kick Podcast with Tim Boreham and subscribe!
Health & Biotech
Health & Biotech
Health & Biotech
